Skip to content

Effects of pressure versus volume controlled mechanical ventilation on intracranial pressure and cerebral perfusion pressure – A pilot study

Effects of pressure versus volume controlled mechanical ventilation on intracranial pressure and cerebral perfusion pressure – A pilot study - Vent-ICP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009832
Enrollment
30
Registered
2015-12-30
Start date
2015-12-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I60.1 S06 I63.1 I61.0

Interventions

Group 1: mechanical ventilation in a pressure-controlled mode for 3 hours Group 2: mechanical ventilation in a volume-controlled mode for 3 hours

Sponsors

Klinikum Kassel, Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - need for mechanical ventilation - need for ICP monitoring - written informed consent by legal proxy

Exclusion criteria

Exclusion criteria: - assisted breathing, spontanious breathing - severe respiratory failure (FiO2 10mmHg) - elevated ICP > 25mmHg and need for ICP therapy within the last 6 hours - Circulatory shock: shock index >1 (Heart frequency/ systolic blood pressure) within the last 6 hours - fever: body temperature >= 38,5°C within the last 6 hours - acidosis: PH 500mg/dl within the last 6 hours - severe respiratory diseases such as lung fibrosis or COPD - prone positioning

Design outcomes

Secondary

MeasureTime frame
- mean ICP and CPP (cerebral perfusion pressure) values - frequency of ICP increases above critical values of 20 mmHg or more - frequency of CPP decreases of 50 mmH or lower - need for ICP therapy - frequency of respiratory complications.

Primary

MeasureTime frame
fluctations of ICP (intracranial pressure) values during pressure-controlled mode ventilation compared to volume-controlled mode ventilation. ICP is measured continuously via intraparenchymatous ICP monitoring. This study had no influence on the indication of ICP monitoring.

Countries

Germany

Contacts

Public ContactChristian Roth

Klinikum Kassel, Neurologische Klinik

christian.roth@klinikum-kassel.de0049 561 980 17219

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026